AC
PRTA icon

Apogem Capital’s Prothena Corp PRTA Stock Holding History

Apogem Capital’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-22,566
Closed -$1.37M – 97
2022
Q3 		$1.37M Sell
22,566
-18,526
-45% -$586K 1.36% 16
2022
Q2 		$1.12M Sell
41,092
-643
-2% -$18.8K 1.01% 24
2022
Q1 		$1.53M Buy
41,735
+8,523
+26% +$307K 1.04% 20
2021
Q4 		$1.64M Buy
33,212
+8,363
+34% +$464K 1.08% 16
2021
Q3 		$1.77M Sell
24,849
-7,255
-23% -$451K 1.13% 17
2021
Q2 		$1.65M Sell
32,104
-14,084
-30% -$439K 1.05% 23
2021
Q1 		$1.16M Sell
46,188
-20,825
-31% -$392K 0.79% 35
2020
Q4 		$805K Buy
+67,013
New +$793K 0.54% 62

Other funds holding PRTA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Apogem Capital's PRTA Position: Q4 2022 in Review

Apogem Capital sold out of Prothena Corp (PRTA) in Q4 2022, closing a stake of 22,566 shares — an estimated $1.37M sold.

Apogem Capital first reported a position in PRTA in Q4 2020 and held it in 8 quarters. The position peaked at $1.77M in Q3 2021. 201 funds tracked by Wall St. Rank hold PRTA as of Q4 2022.

  • Apogem Capital reported no remaining Prothena Corp position as of Q4 2022 after selling out during the quarter.
  • Apogem Capital sold 22,566 Prothena Corp shares in Q4 2022, an estimated $1.37M.
  • Apogem Capital first reported a position in Prothena Corp in Q4 2020 and held it in 8 quarters.
  • Apogem Capital's Prothena Corp position peaked at $1.77M in Q3 2021.
  • 201 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2022.

Based on Apogem Capital's 13F filing for Q4 2022, filed 13 Feb 2023.